“…The mechanisms responsible for these metabolic responses are likely numerous, although the release of cyclooxygenase (COX)-derived vasoconstricting prostanoids and other eicosanoid metabolites of arachidonic acid plays a key role ( Fordsmann et al, 2013 , Gariepy et al, 2017 , Shibata et al, 1992 ). Reduced blood flow and tissue oxygenation can trigger a migraine attack in susceptible individuals ( Appenzeller, 1994 , Arngrim et al, 2016 , Broessner et al, 2016 , Frank et al, 2020 , Schoonman et al, 2006 ). These findings, together with the notion that reduced blood flow and tissue oxygenation lead to the sensitization of nociceptors in other tissues ( Hillery et al, 2011 , MacIver and Tanelian, 1992 , Mense and Stahnke, 1983 ), raises the possibility that the mechanisms responsible for driving dural nociceptors in the wake of CSD involve similar vascular and metabolic changes.…”